go back

Lisocabtagene Maraleucel (Breyanzi) CAR-T Therapy

Hawaii rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Professionalmedian $562,341 · 10th–90th $537,032$602,5600%50%10th90th$562,341$1.0K$5.0K$20.0K$100.0K$500.0K$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$588,843.66
Cigna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$676,082.98
HMSA
Setting
Professional
Modifier
Global
Typical Low
$537,031.80
Median
$537,031.80
Typical High
$537,031.80
Kaiser Permanente
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$676,082.98
Typical High
$851,138.04
United
Setting
Professional
Modifier
Global
Typical Low
$61,659.50
Median
$436,515.83
Typical High
$4,168,693.83